Microbot Medical Files 8-K with Regulatory Updates
Ticker: MBOT · Form: 8-K · Filed: Jun 3, 2024 · CIK: 883975
| Field | Detail |
|---|---|
| Company | Microbot Medical Inc. (MBOT) |
| Form Type | 8-K |
| Filed Date | Jun 3, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-disclosure
TL;DR
Microbot Medical filed an 8-K on June 3rd, check for regulatory updates and financial docs.
AI Summary
Microbot Medical Inc. filed an 8-K on June 3, 2024, to report on several items including a Regulation FD Disclosure and Other Events. The filing also includes financial statements and exhibits. The company's principal executive offices are located at 288 Grove Street, Suite 388, Braintree, MA 02184.
Why It Matters
This 8-K filing provides important updates and disclosures from Microbot Medical Inc. to investors and the public, covering regulatory information and other significant events.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting standard disclosures and does not appear to contain significant negative news.
Key Players & Entities
- Microbot Medical Inc. (company) — Registrant
- June 3, 2024 (date) — Date of earliest event reported
- 288 Grove Street, Suite 388, Braintree, MA 02184 (address) — Principal Executive Offices
FAQ
What specific events are being disclosed under Regulation FD?
The filing indicates a Regulation FD Disclosure, but the specific details of the disclosure are not provided in the provided text snippet.
What type of 'Other Events' are reported in this 8-K?
The filing lists 'Other Events' as an item, but the specific nature of these events is not detailed in the provided text.
When was the earliest event reported in this 8-K?
The earliest event reported in this 8-K was on June 3, 2024.
What is the principal executive office address for Microbot Medical Inc.?
The principal executive offices are located at 288 Grove Street, Suite 388, Braintree, MA 02184.
What is the Commission File Number for Microbot Medical Inc.?
The Commission File Number for Microbot Medical Inc. is 000-19871.
Filing Stats: 804 words · 3 min read · ~3 pages · Grade level 11.5 · Accepted 2024-06-03 08:20:23
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value MBOT NASDAQ Capital Mark
Filing Documents
- form8-k.htm (8-K) — 42KB
- ex99-1.htm (EX-99.1) — 12KB
- ex99-1_001.jpg (GRAPHIC) — 7KB
- 0001493152-24-022309.txt ( ) — 239KB
- mbot-20240603.xsd (EX-101.SCH) — 3KB
- mbot-20240603_lab.xml (EX-101.LAB) — 33KB
- mbot-20240603_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
01 of this Current Report on Form 8-K contains "forward-looking statements." Such statements which are not purely
Item 8.01 of this Current Report on Form 8-K contains "forward-looking statements." Such statements which are not purely historical (including, but not limited to statements that contain words such as "will," "believes," "plans," "anticipates," "expects," "intends," "would," "could" and "estimates") are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, regulatory milestones. Actual results could differ from those projected in any forward-looking statements due to numerous factors. These forward-looking statements are made as of the date of this Form 8-K, and the Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by law. Although the Company believes that the beliefs, plans, expectations and intentions contained in this Form 8-K are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the Company's reports and statements filed from time-to-time with the Securities and Exchange Commission. Item 9.01. Financial (d) Exhibits Exhibit Number Description 99.1 Press Release 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MICROBOT MEDICAL INC. By: /s/ Harel Gadot Name: Harel Gadot Title: Chief Executive Officer, President and Chairman Date: June 3, 2024